Clinical Trials Browser

Phase 3 × Lymphoma, Mantle-Cell × venetoclax × Clear all

NCT03112174 2025-07-22

SYMPATICO

Phase 3 Completed

366 enrolled 45 charts

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT06496308 2024-07-11

Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment

Phase 3 Recruiting

Lymphoma, Mantle-Cell